Improvement Image Quality for SuperSonic® MACH Ultrasound System
Launched by SUPERSONIC IMAGINE · Apr 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focusing on improving the quality of images produced by the SuperSonic® MACH Ultrasound System. The goal is to gather feedback from radiologists—doctors who specialize in interpreting medical images—about the ultrasound images they see. This feedback will help enhance the ultrasound technology for future use, making it more effective for diagnosing various conditions.
To be eligible for this study, participants must be at least 18 years old or, if they are younger, have a legal representative who can provide consent. Additionally, they should be scheduled for at least one routine ultrasound and have health insurance. Participants will simply need to undergo their usual ultrasound procedure, and their feedback will be collected afterward. It’s important to note that individuals with certain conditions, like a latex allergy or open wounds, may not be able to participate. Overall, this trial aims to make ultrasound imaging better for everyone in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is ≥ 18 years old and is able to understand and sign the informed consent form.
- • Subject is a minor \< 18 years old and the legal representative has signed the informed consent form.
- • Subject is scheduled for at least one or more routine ultrasounds.
- • Subject is affiliated to National Social Insurance or a Health Insurance Regimen.
- Exclusion Criteria:
- • Subject is unable or unwilling to adhere to Study procedures.
- • Subject or his/her legal representative if a minor is unable to express or understand informed consent.
- • Subject is under legal protection
- • Subject is deprived of liberty by judicial or administrative decision
- • Subject undergoes psychiatric treatment under constraint
- • Subject is admitted to a health or social establishment for purposes other than research
- • Subject has latex allergy.
- • Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure
About Supersonic Imagine
Supersonic Imagine is a pioneering medical technology company specializing in advanced ultrasound imaging solutions. With a commitment to innovation and excellence, the company develops cutting-edge diagnostic tools that enhance the accuracy and efficiency of medical imaging. Their proprietary technologies leverage state-of-the-art imaging techniques to provide healthcare professionals with valuable insights for improved patient care. By focusing on research and development, Supersonic Imagine aims to revolutionize the field of ultrasound diagnostics, making significant contributions to clinical practice and patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, Ile De France, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported